| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |